CYP19A1 and breast carcinoma: Overexpressed in aromatase inhibitor resistant estrogen receptor-positive (ER+) breast cancer; deleted in colon cancer; expression progressively decreased across breast cancer progression model; expression pattern can distinguish the gastric cancer grades and the control; regulation of apoptosis/cell proliferation